OBJECTIVES: To examine and summarize current international guidelines regarding cardiovascular risk reduction before and during cancer

 

Abstract

OBJECTIVES: To examine and summarize current international guidelines regarding cardiovascular risk reduction before and during cancer therapy, and to discuss the emerging role of cardio-oncology as a subspecialty in cancer care and the role of cardio-oncology rehabilitation.

DATA SOURCES: Published articles and guidelines.

CONCLUSION: With improvements in cancer detection and the use of novel adjuvant therapies, an increasing number of individuals now survive a cancer diagnosis. However, for some the cost is high - many survivors are now at higher risk of death from cardiovascular disease than from recurrent cancer. Cardiovascular morbidity and mortality are common and associated with common cancer therapies serially administered in adult oncology care.

IMPLICATIONS FOR NURSING PRACTICE: Timely risk-reduction interventions hold promise in reducing cardiovascular morbidity and mortality. Oncology nurses are the key providers to identify baseline risks, perform necessary referrals, provide individualized teaching, and support the patient within the family and community.

PMID: 31983487 [PubMed - as supplied by publisher]

14:44

Photo

Not included, change data exporting settings to download.

256×256, 6.0 KB

14:44

In reply to this message

pubmed: ctoall&ca or conall

Modulating the cardiotoxic behaviour of immunoglobulin light chain dimers through point mutations.

//www.ncbi.nlm.nih.gov/corehtml/query/egifs/http:--www.tandfonline.com-templates-jsp-_style2-_tandf-images-tandf100x25.gif Related Articles

Modulating the cardiotoxic behaviour of immunoglobulin light chain dimers through point mutations.

Amyloid. 2019;26(sup1):105-106

Authors: Maritan M, Ambrosetti A, Oberti L, Barbiroli A, Diomede L, Romeo M, Lavatelli F, Sormanni P, Palladini G, Bolognesi M, Merlini G, Ricagno S

PMID: 31343361 [PubMed - indexed for MEDLINE]

29 January 2020

14:32

Cancer & Heart (Cardio-Oncology, Cardiotoxicity, TEV)

Photo

Not included, change data exporting settings to download.

256×256, 6.0 KB

14:32

In reply to this message

pubmed: caandvteortroorpul

Incidence and outcomes of heparin-induced thrombocytopenia in solid malignancy: an analysis of the National Inpatient Sample Database.

Related Articles

Incidence and outcomes of heparin-induced thrombocytopenia in solid malignancy: an analysis of the National Inpatient Sample Database.

Br J Haematol. 2020 Jan 28;:

Authors: Kumar R, Bhandari S, Singh SRK, Malapati S, Cisak KI